Lupin gets USFDA nod for generic contraceptive tablets Ruby Khatun Khatun15 Dec 2017 10:30 AM ISTNew Delhi: Drug major Lupin said it has received approval from the US health regulator to market its Tydemy tablets, used to prevent pregnancy, in the...
Glenmark completes phase 3 study for nasal spray Ruby Khatun Khatun15 Dec 2017 10:15 AM ISTNew Delhi: Glenmark Pharmaceuticals said it has completed phase 3 study of its investigational fixed-dose combination nasal spray and plans to submit...
USFDA accepts application for Indivior's new schizophrenia drug Ruby Khatun Khatun15 Dec 2017 9:45 AM ISTU.S. Food and Drug Administration (FDA) accepted Indivior's application for its new schizophrenia treatment, the British drugmaker said on Tuesday,...
Zydus gets USFDA nod for schizophrenia drug Ruby Khatun Khatun11 Dec 2017 11:00 AM ISTNew Delhi: Zydus Pharmaceuticals (USA) Inc has received final approval from the US health regulator to market Clozapine tablets, used in the treatment...
Indiabulls Pharma raises Rs 155 crore from Clermont Group Ruby Khatun Khatun9 Dec 2017 2:53 PM ISTMumbai: Indiabulls Pharmaceuticals has raised Rs 155 crore from Singapore-based investment firm Clermont Group.Indiabulls Pharmaceuticals is a wholly...
Dr Reddy's gets EIR for Hyderabad facility Ruby Khatun Khatun4 Dec 2017 10:45 AM ISTNew Delhi: Drug firm Dr. Reddy's Laboratories today said it has received establishment inspection report (EIR) from the US health regulator for its...
Panacea Biotec gets USFDA nod to file for generic cancer drug Ruby Khatun Khatun2 Dec 2017 10:00 AM ISTNew Delhi: Panacea Biotec said the US health regulator has accepted its filing for approval of generic version of cancer treatment injection...
Securities class action lawsuit served on Dr Reddys in US Ruby Khatun Khatun1 Dec 2017 10:41 AM ISTNew Delhi: Drug firm Dr. Reddy's Laboratories on Wednesday said it has been served a securities class action lawsuit in the US for alleged violations...
Zydus Cadila gets USFDA nod for blood pressure treatment drug Ruby Khatun Khatun30 Nov 2017 10:45 AM ISTNew Delhi: Cadila Healthcare said group firm Zydus Cadila has received final approval from the US health regulator to market Candesartan Cilexetil and...
Zydus gets USFDA nod for seizure, migraine drug Ruby Khatun Khatun28 Nov 2017 1:53 PM ISTNew Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market Topiramate extended-release capsules,...
Aurobindo looks for inorganic growth prospects in East Europe Ruby Khatun Khatun27 Nov 2017 10:40 AM ISTMumbai: Hyderabad-based Aurobindo Pharma is looking at inorganic growth opportunities in Eastern Europe and other geographies for deeper market...
Zydus Cadila gets USFDA nod to sell erectile dysfunction drug Ruby Khatun Khatun24 Nov 2017 11:05 AM ISTNew Delhi: Drug firm Zydus Cadila said it has received approval from the US health regulator to market Tadalafil tablets, used for the treatment of...
